DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Plain-language summary

This study performs DNA analysis of tumor tissue from patients with Acute Myeloid Leukemia (AML). It included AML patients enrolled on a prior clinical trial (ECOG-E1900). It is a non-phase laboratory analysis study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

ECOG-ACRIN Cancer Research Group

Intervention

DNA methylation analysis, comparative genomic hybridization, fluorescence in situ hybridization, microarray analysis, polymerase chain reaction, diagnostic laboratory biomarker analysis, immunologic technique

Start date

3/23/2006

Estimated completion

10/15/2009

Related genes

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

DISEASE CHARACTERISTICS:

* Diagnosis of acute myeloid leukemia
* Enrolled on clinical trial ECOG-E1900

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* Not specified